98 related articles for article (PubMed ID: 38722284)
1. Amentoflavone reverses epithelial-mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis.
Jian HY; Zhang JT; Liu Z; Zhang Z; Zeng PH
J Cell Mol Med; 2024 Jun; 28(11):e18442. PubMed ID: 38842135
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of DCTN2 and its tumour-promoting role in HCC by modulating the AKT pathway.
Xu S; Xing J; Li K; Qiao L; Zhang C; Ren Y; Liu Y
J Cell Mol Med; 2024 Jun; 28(11):e18450. PubMed ID: 38842133
[TBL] [Abstract][Full Text] [Related]
3. The HHEX-ABI2/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC.
Li H; Liu J; Lai J; Su X; Wang X; Cao J; Mao S; Zhang T; Gu Q
J Transl Med; 2024 Jun; 22(1):537. PubMed ID: 38844969
[TBL] [Abstract][Full Text] [Related]
4. SOAT1 regulates cholesterol metabolism to induce EMT in hepatocellular carcinoma.
Fu R; Xue W; Liang J; Li X; Zheng J; Wang L; Zhang M; Meng J
Cell Death Dis; 2024 May; 15(5):325. PubMed ID: 38724499
[TBL] [Abstract][Full Text] [Related]
5. RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma.
You K; Du X; Zhao Y; Wen F; Lu Z; Fan H
J Cancer Res Clin Oncol; 2024 May; 150(5):245. PubMed ID: 38722372
[TBL] [Abstract][Full Text] [Related]
6. Metadherin-driven promotion of cancer stem cell phenotypes and its effect on immunity in hepatocellular carcinoma.
Todorović N; Amedei A
World J Gastroenterol; 2024 May; 30(20):2624-2628. PubMed ID: 38855151
[TBL] [Abstract][Full Text] [Related]
7. TEDC2 plays an oncogenic role and serves as a therapeutic target of hepatocellular carcinoma.
Li Y; Guo B; Wang L; Zhou F; Yu Z; Huang Y; Chen R; Zhang M; Zhang K; Zheng L; Jing S; Hong W; Han T
Dig Liver Dis; 2024 May; 56(5):861-871. PubMed ID: 37867019
[TBL] [Abstract][Full Text] [Related]
8. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
[TBL] [Abstract][Full Text] [Related]
9. Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma.
Zuo A; Li J; Weng S; Xu H; Zhang Y; Wang L; Xing Z; Luo P; Cheng Q; Li J; Han X; Liu Z
J Proteome Res; 2024 May; 23(5):1821-1833. PubMed ID: 38652053
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.
Villanueva A; Alsinet C; Yanger K; Hoshida Y; Zong Y; Toffanin S; Rodriguez-Carunchio L; Solé M; Thung S; Stanger BZ; Llovet JM
Gastroenterology; 2012 Dec; 143(6):1660-1669.e7. PubMed ID: 22974708
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Analysis of HOXB13 Expression in Hepatocellular Carcinoma.
Jeong EA; Lee MH; Bae AN; Kim J; Park JH; Lee JH
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792899
[No Abstract] [Full Text] [Related]
12. Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma.
Yang S; Zheng L; Li L; Zhang J; Wang J; Zhao H; Chen Y; Liu X; Gan H; Chen J; Yan M; He C; Li K; Ding C; Li Y
Clin Transl Med; 2024 Jun; 14(6):e1727. PubMed ID: 38804617
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma.
Roy SK; Srivastava S; McCance C; Shrivastava A; Morvant J; Shankar S; Srivastava RK
J Cell Mol Med; 2024 May; 28(9):e18295. PubMed ID: 38722284
[TBL] [Abstract][Full Text] [Related]
14. PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma.
Hu X; He Y; Han Z; Liu W; Liu D; Zhang X; Chen L; Qi L; Chen L; Luo Y; Li Q; Chen P; Wu Q; Zhu X; Guo H
Cell Death Dis; 2022 Nov; 13(11):1010. PubMed ID: 36446769
[TBL] [Abstract][Full Text] [Related]
15. The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer.
Jiang N; Hu Y; Wang M; Zhao Z; Li M
Breast Cancer (Dove Med Press); 2022; 14():291-309. PubMed ID: 36193236
[TBL] [Abstract][Full Text] [Related]
16. Structure and mechanism of the γ-secretase intramembrane protease complex.
Wolfe MS; Miao Y
Curr Opin Struct Biol; 2022 Jun; 74():102373. PubMed ID: 35461161
[TBL] [Abstract][Full Text] [Related]
17. Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer.
Li J; Liu L; Chen Y; Wu M; Lin X; Shen Z; Cheng Y; Chen X; Weygant N; Wu X; Wei L; Sferra TJ; Han Y; Chen X; Shen A; Shen A; Peng J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445733
[TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin-1β and inflammation in lung cancer.
Zhang J; Veeramachaneni N
Biomark Res; 2022 Jan; 10(1):5. PubMed ID: 35086565
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
